SPPI Aperçu des actions
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology drug products.
Score flocon de neige | |
---|---|
Évaluation | 6/6 |
Croissance future | 5/6 |
Performances passées | 0/6 |
Santé financière | 3/6 |
Dividendes | 0/6 |
Récompenses
Analyse des risques
Spectrum Pharmaceuticals, Inc. Concurrents
Historique des prix et performances
Historique des cours de bourse | |
---|---|
Prix actuel de l'action | US$1.03 |
Plus haut sur 52 semaines | US$1.57 |
Plus bas sur 52 semaines | US$0.32 |
Bêta | 2.14 |
1Variation sur 1 mois | 4.54% |
Variation sur 3 mois | -1.90% |
Variation sur 1 an | 17.05% |
3Variation sur 3 ans | -71.39% |
Variation sur 5 ans | -95.10% |
Évolution depuis l'introduction en bourse | -99.25% |
Nouvelles et mises à jour récentes
Recent updates
Analysts Just Made A Huge Upgrade To Their Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Forecasts
May 14Earnings Update: Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Just Reported And Analysts Are Boosting Their Estimates
May 12Spectrum plunges 28% after FDA scientists question poziotinib evidence for NSCLC
Sep 20Is Spectrum Pharmaceuticals (NASDAQ:SPPI) In A Good Position To Invest In Growth?
Sep 16Spectrum Pharmaceuticals stock jumps 10% afterhours on FDA nod for Rolvedon injection
Sep 09Spectrum Pharmaceuticals: Revisiting This 'Soap Opera'
Aug 21Spectrum Pharmaceuticals Q2 2022 Earnings Preview
Aug 10Here's Why We're A Bit Worried About Spectrum Pharmaceuticals' (NASDAQ:SPPI) Cash Burn Situation
Jun 04Spectrum Pharmaceuticals: Some Last Words
Feb 25Here's Why We're Watching Spectrum Pharmaceuticals' (NASDAQ:SPPI) Cash Burn Situation
Oct 05Spectrum Pharmaceuticals' CRL: There Is Very Little Clarity
Aug 12Spectrum's Big Approval: Any Day Now
Jul 29FDA initiates pre-approval inspection for Spectrum pharmaceuticals' ROLONTIS
Jun 01Here's Why We're Watching Spectrum Pharmaceuticals' (NASDAQ:SPPI) Cash Burn Situation
May 31We're Keeping An Eye On Spectrum Pharmaceuticals' (NASDAQ:SPPI) Cash Burn Rate
Feb 12Spectrum Pharma drops after announcing less-than-favorable Phase 2 data
Dec 22Here's What Spectrum Pharmaceuticals, Inc.'s (NASDAQ:SPPI) Shareholder Ownership Structure Looks Like
Dec 21Spectrum Pharma Is Down But Not Out
Nov 16Spectrum Shareholders In Limbo As FDA Delays Rolontis Decision Date, Agrees To Discuss Poziotinib
Nov 11Rendement pour les actionnaires
SPPI | US Biotechs | US Marché | |
---|---|---|---|
7D | 5.3% | -0.7% | -1.6% |
1Y | 17.0% | 19.8% | 30.8% |
Rendement vs Industrie: SPPI exceeded the US Biotechs industry which returned -4.2% over the past year.
Rendement vs marché: SPPI exceeded the US Market which returned 14.1% over the past year.
Volatilité des prix
SPPI volatility | |
---|---|
SPPI Average Weekly Movement | 7.2% |
Biotechs Industry Average Movement | 9.6% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 14.9% |
10% least volatile stocks in US Market | 2.9% |
Cours de l'action stable: SPPI's share price has been volatile over the past 3 months.
Volatilité au fil du temps: SPPI's weekly volatility has decreased from 15% to 7% over the past year.
À propos de l'entreprise
Fondée | Salariés | PDG | Site web |
---|---|---|---|
1987 | 86 | Tom Riga | www.sppirx.com |
Spectrum Pharmaceuticals, Inc. Résumé des fondamentaux
SPPI statistiques fondamentales | |
---|---|
Capitalisation boursière | US$209.89m |
Bénéfices(TTM) | -US$67.71m |
Recettes(TTM) | US$25.73m |
8.2x
Ratio P/S-3.1x
Ratio P/ELe site SPPI est-il surévalué ?
Voir Juste valeur et analyse de l'évaluationBénéfices et recettes
SPPI compte de résultat (TTM) | |
---|---|
Recettes | US$25.73m |
Coût des recettes | US$2.86m |
Marge brute | US$22.87m |
Autres dépenses | US$90.58m |
Les revenus | -US$67.71m |
Derniers bénéfices déclarés
Mar 31, 2023
Prochaine date de publication des résultats
s/o
Résultat par action (EPS) | -0.33 |
Marge brute | 88.90% |
Marge bénéficiaire nette | -263.16% |
Ratio dettes/capitaux propres | 107.6% |
Quelles ont été les performances à long terme de SPPI?
Voir les performances historiques et les comparaisons